Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1172-1181
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1172
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1172
Variable | S arm (n = 174) | S + R arm (n = 56) | P value |
Sex | 0.656 | ||
Male | 159 (91.4) | 49 (87.5) | |
Female | 15 (8.6) | 7 (12.5) | |
Age (yr) | 0.056 | ||
<60 | 106 (60.9) | 42 (75.0) | |
≥60 | 68 (39.1) | 14 (25.0) | |
Pathological differentiation | 0.586 | ||
Poor | 66 (37.5) | 1 (1.8) | |
Moderate | 97 (55.7) | 33 (58.9) | |
Well | 10 (5.7) | 22 (39.3) | |
Tumor location | 0.031a | ||
Upper | 15 (8.6) | 3 (5.4) | |
Middle | 98 (56.3) | 22 (39.3) | |
Lower | 61 (35.1) | 31 (55.4) | |
Lymph node dissection | 0.448 | ||
2-field resection | 139 (79.9) | 49 (87.5) | |
3-field resection | 28 (16.1) | 7 (12.5) | |
No. of LNs involved | 0.740 | ||
≤2 | 113 (64.9) | 35 (62.5) | |
≥3 | 61 (35.1) | 21 (37.5) | |
No. of LNs dissected | 0.569 | ||
<12 | 2 (1.1) | 1 (1.8) | |
≥12 | 172 (98.9) | 55 (98.2) | |
T stage | 0.075 | ||
T3 | 164 (94.3) | 48 (85.7) | |
T4 | 10 (5.7) | 8 (14.3) | |
Chemotherapy | 0.978 | ||
Yes | 106 (60.9) | 34 (60.7) |
Type of failure | S arm (n = 174) | S + R arm (n = 56) | P value |
Failure patterns | < 0.001 | ||
Distant metastasis | 14 (8.0) | 36 (64.3) | |
Locoregional recurrence | 141 (81.0) | 14 (25.0) | |
Mixed failure | 19 (11.0) | 6 (10.7) | |
Distant metastasis | < 0.001 | ||
Distant metastasis | 33 (19.0) | 42 (75.0) | |
Others | 141 (81.0) | 14 (25.0) | |
Locoregional failure | < 0.001 | ||
Locoregional recurrence | 160 (92.0) | 20 (78.3) | |
Others | 14 (8.0) | 36 (21.7) |
Univariate analysis | Multivariate analysis | ||||
Median DFS (mo) | χ2 value | P value | HR (95%CI) | P value | |
Sex | 0.841 (0.532-1.328) | 0.457 | |||
Male | 9.5 | 0.309 | 0.579 | ||
Female | 8 | ||||
Age (yr) | 0.712 (0.530-0.957) | 0.024 | |||
< 60 | 9 | 1.023 | 0.312 | ||
≥ 60 | 9.5 | ||||
Pathological differentiation | 1.128 (0.094-1.934) | 0.071 | |||
Poor | 8 | 6.377 | 0.095 | ||
Moderate | 10.4 | ||||
Well | 9.5 | ||||
Tumor location | 1.423 (0.849-2.386) | 0.363 | |||
Upper | 6.6 | 3.277 | 0.194 | ||
Middle | 9.9 | ||||
Lower | 8.8 | ||||
Lymph node dissection | 0.531 (0.222-1.186) | 0.107 | |||
2-field resection | 9 | 3.462 | 0.177 | ||
3-field resection | 8 | ||||
No. of LNs involved | 1.843 (1.369-2.482) | <0.001a | |||
≤ 2 | 11 | 13.483 | < 0.001 | ||
≥ 3 | 8 | ||||
No. of LN dissected | 1.460 (0.459-4.644) | 0.522 | |||
< 12 | 7 | 0.656 | 0.418 | ||
≥ 12 | 9.5 | ||||
Chemotherapy | 0.732 (0.552-0.971) | 0.031 | |||
Yes | 8 | 1.769 | 0.183 | ||
No | 10 | ||||
T stage | 0.697 (0.441-1.124) | 0.132 | |||
T3 | 9 | 0.087 | 0.767 | ||
T4 | 8 | ||||
Radiotherapy | - | - | - | 0.667 (0.487-0.915) | 0.012a |
- Citation: Zeng Y, Yu W, Liu Q, Yu WW, Zhu ZF, Zhao WX, Liu J, Wang JM, Fu XL, Liu Y, Cai XW. Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy. World J Gastrointest Oncol 2019; 11(12): 1172-1181
- URL: https://www.wjgnet.com/1948-5204/full/v11/i12/1172.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i12.1172